Back to

Alabama

Biologics Compliance Guide for Clinics in Alabama

Up-to-date information on protocols, safety, and regulations to help you deliver advanced patient care.

1. Summary

This guide provides Alabama clinics with a clear roadmap to establish biologic treatments in compliance with federal and state regulations. Understanding the qualifications and protocols required ensures that providers can deliver safe, legally compliant stem cell therapies to patients in need.

2. FDA Compliance

The U.S. Food and Drug Administration (FDA) oversees human cells, tissues, and cellular and tissue-based products (HCT/P) through guidelines outlined in FDA’s HCT/P regulations. These guidelines cover:

• Classification and criteria for products qualifying as HCT/Ps
• Ensuring minimal manipulation of cells and homologous use
• Registration and listing requirements with the FDA

Clinics must ensure that all biologic therapies meet FDA standards for safety and efficacy, aligning with these criteria to remain compliant.

3. Alabama State Regulations

Alabama has specific regulations governing the use of stem cell therapies. For state-specific compliance, clinics should refer to the Alabama Department of Public Health. Key points include:

• Licensing and oversight requirements for clinics offering HCT/P services
• Safety and sanitation standards specific to biologic handling
• Must be a licensed physician (MD/DO)

Following Alabama’s regulatory guidelines helps ensure accessible, safe practice for clinics interested in offering biologic therapies.

4. Provider Qualifications

In Alabama, certain licensed medical providers are qualified to administer stem cell therapies, such as physicians, osteopaths, and registered nurses under appropriate supervision. To learn more about licensure and credentialing in Alabama, refer to the Alabama Board of Medical Examiners.

5. Patient Informed Consent

Informed consent is critical for biologic therapies. In Alabama, informed consent must cover:

• Potential benefits and risks associated with stem cell therapies
• The experimental nature of some stem cell procedures
• A statement that efficacy may vary depending on the individual

Consent should be documented and retained in patient records to protect both the clinic and patient.

6. Additional Compliance Requirements

Adhering to clear pre- and post-treatment protocols helps ensure safe treatment outcomes. Providers are encouraged to develop protocols that align with Alabama and federal safety guidelines.

Clinics should establish written SOPs for biologic handling, preparation, and patient follow-up. SOPs are key to maintaining compliance and providing consistent patient care.

Clinics are advised to carry medical liability insurance that covers biologic treatments. This insurance helps manage risk and is essential for clinics offering experimental or emerging therapies.

When marketing biologic therapies, Alabama clinics must avoid false or misleading claims. Marketing materials should be compliant with both Alabama advertising standards and Federal Trade Commission (FTC) advertising guidelines.

This guide is provided as an informational resource to help clinics and practitioners understand general compliance requirements for biologics in Alabama. It is not intended to serve as legal advice or replace consultation with qualified legal professionals. Regulations may vary and are subject to change; clinics and practitioners should consult legal counsel or regulatory experts for advice specific to their circumstances and ensure full compliance with all applicable federal and state laws. The authors and publishers of this guide disclaim any liability arising from its use or reliance on the information provided.